Antiprogestogen
This page covers all Antiprogestogen drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Progesterone receptor.
Targets
Phase 3 pipeline (1)
- mifegyne and cytotec · Western Galilee Hospital-Nahariya · Women's health
Mifepristone blocks progesterone receptors, while misoprostol induces uterine contractions.
Patent intelligence
- antiprogestogen patent landscape — aggregated cliff calendar, attackable patents, originator estates